Abstract: A process for the production and for the winding of one polyester yarn, preferably multi-filament yarn, which comprises at least about 85 weight %, in relation to the total weight of the polyester yarn, of polytrimethylene terephthalate (PTT) wherein said process is characterized in that filaments of said polyester yarn is heat-treated, before it is wound on a bobbin, at a temperature in the range of about 70° C. to about 180° C. The method of accomplishing this is by heating the godets that are used in the spinning part of the process, preferably the last pair of godets, to relax the yarns so that the yarn package will not shrink significantly during storage and/or transportation. It is thus possible to obtain at least one PTT yarn package with long-term stability during storage and which is insensitive against elevated temperatures during storage and transport.

Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a condensed soy molasses material. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.

Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.

Abstract: A health supplement composition is disclosed. The health supplement composition contains a solid health supplement material that is separated from a soy molasses material. The soy molasses material is derived from a soy material selected from soy flour, soy flakes, soy grit, or soy meal. The solid health supplement material contains at least two isoflavones where one of the isoflavones is either glycitein or glycitin.